EV/EBITDA
-11.21
+1.24+9.96%
5 min ago
Summary
- As of February 26, 2025, TSHA EV/EBITDA is -11.21, with a rise of +1.24 (+9.96%) during the most recent trading day.
- Over the past year, TSHA EV/EBITDA has dropped by -7.87 (-235.63%).
- TSHA EV/EBITDA is now -12355.56% below its all-time high of -0.09.
Performance
TSHA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TSHA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +10.0% | -9.9% | -7.3% |
| 1 m1 month | -5.2% | +5.1% | +3.6% |
| 3 m3 months | +54.1% | -54.1% | -45.6% |
| 6 m6 months | -278.7% | -29.3% | -26.2% |
| ytdytd | +8.5% | -8.5% | -6.2% |
| 1 y1 year | -235.6% | -34.0% | -31.3% |
| 5 y5 years | - | - | - |
TSHA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.3% | -13.54 | +17.2% | |
| 3 m | 3-month | -10.26 | -9.3% | -27.82 | +59.7% |
| 6 m | 6-month | -2.64 | -324.6% | -27.82 | +59.7% |
| 1 y | 1-year | -2.54 | -341.3% | -27.82 | +59.7% |
| 3 y | 3-year | -0.09 | <-9999.0% | -27.82 | +59.7% |
| 5 y | 5-year | -0.09 | <-9999.0% | -31.19 | +64.1% |
| alltime | all time | -0.09 | <-9999.0% | -31.19 | +64.1% |
Taysha Gene Therapies EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.21(-8.5%) |
| 2024 | -12.25(+412.6%) |
| 2023 | -2.39(+236.6%) |
| Date | Value |
|---|---|
| 2022 | -0.71(-66.2%) |
| 2021 | -2.10(-83.2%) |
| 2020 | -12.52 |
FAQ
- What is Taysha Gene Therapies EV/EBITDA?
- What is the all time high EV/EBITDA for Taysha Gene Therapies?
- What is TSHA EV/EBITDA year-to-date change?
- What is Taysha Gene Therapies EV/EBITDA year-on-year change?
What is Taysha Gene Therapies EV/EBITDA?
The current EV/EBITDA of TSHA is -11.21
What is the all time high EV/EBITDA for Taysha Gene Therapies?
Taysha Gene Therapies all-time high EV/EBITDA is -0.09
What is TSHA EV/EBITDA year-to-date change?
Taysha Gene Therapies EV/EBITDA has changed by +1.04 (+8.49%) since the beginning of the year
What is Taysha Gene Therapies EV/EBITDA year-on-year change?
Over the past year, TSHA EV/EBITDA has changed by -7.87 (-235.63%)